BRIEF-Psyence Biomed Announces Strategic Ibogaine Investment
Reuters2026/09/23 11:04Psyence Biomedical Ltd PBM.O:
PSYENCE BIOMED ANNOUNCES STRATEGIC IBOGAINE INVESTMENT
PSYENCE BIOMEDICAL -AGREES TO INVEST UP TO $5 MILLION IN PSYLABS, $2.40 MILLION COMMITTED
PSYENCE BIOMEDICAL - CO AND PSYLABS AGREE TO $9 MILLION VALUE-MATCHED SHARE EXCHANGE
PSYENCE BIOMEDICAL - POST-DEAL, PSYLABS TO HOLD 49.89% OF PSYENCE BIOMED, PSYENCE BIOMED 41.13% OF PSYLABS
Source text: ID:nGNX8m9Ck4
Further company coverage: PBM.O
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Iran’s seven-day reopening plan for the Hormuz Strait was rejected by Trump; Brent crude oil rises above $106
Iran insists on a seven-day proposal to reopen the Strait of Hormuz, but this plan has been rejected by U.S. President Trump, which may further delay the reopening of this crucial waterway.
New York Silver Futures Drop 1% to $64.15 per Ounce
Bitcoin Price Forecast: Can BTC USD Hit $90K Ahead of October’s FOMC Meeting?
Gold Fields said to express interest in buying Northern Star
Crypto prices
More
